Journey Medical Corporati...

NASDAQ: DERM · Real-Time Price · USD
6.96
-0.30 (-4.13%)
At close: Aug 15, 2025, 3:59 PM
6.33
-9.11%
After-hours: Aug 15, 2025, 07:45 PM EDT

Journey Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
56.4M 56.24M 56.13M 57.77M 77.68M 80M 79.18M 79.89M 61.47M 62.59M 73.67M 75.22M 78.71M 75.71M 63.13M 59.34M 49.18M 43.3M
Cost of Revenue
12.31M 18.85M 20.88M 24.66M 25.8M 27.03M 26.66M 28.36M 29.16M 29.02M 30.77M 32.58M 36.53M 36.38M 32.08M 26.84M 19.05M 14.69M
Gross Profit
29.08M 37.39M 35.26M 33.11M 51.88M 52.97M 52.52M 51.53M 32.31M 33.56M 42.89M 42.64M 42.19M 39.33M 31.05M 32.5M 30.13M 28.61M
Operating Income
-6.86M -6.91M -13.68M -18.02M 2.12M -2.6M -2.07M -9.96M -36.7M -36.19M -27.54M -26.86M -30.02M -36.64M -35.14M -22.2M -9.31M 5.99M
Interest Income
390K 689K 757K 679K 499K 417K 322K 259K 254K 179K 60K 10K 7K 3K n/a n/a n/a n/a
Pretax Income
-8.62M -8.24M -14.61M -18.21M 1.06M -3.94M -3.63M -12.24M -39.2M -38.43M -29.57M -32.35M -36.3M -44M -42.36M -25.52M -11.45M 5.22M
Net Income
-8.74M -8.3M -14.67M -18.34M 843K -4.16M -3.85M -12.35M -39.22M -38.39M -29.63M -40.74M -41.3M -45.64M -43.99M -19.74M -9.07M 3.25M
Selling & General & Admin
43.91M 42.35M 40.2M 39.98M 37.23M 39.04M 43.91M 48.06M 54.99M 58.05M 59.47M 60.54M 55.72M 48.32M 39.83M 30.59M 25.67M 22.62M
Research & Development
1.1M 2.01M 9.86M 11.14M 12.53M 13.39M 7.54M 10.29M 10.88M 11.71M 10.94M 8.68M 6.66M 17.82M 16.56M 14.57M 13.77M n/a
Other Expenses
5.94M -64K -1.13M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
50.95M 44.3M 48.93M 51.13M 49.76M 52.43M 51.45M 58.35M 65.87M 69.75M 70.41M 69.22M 62.38M 66.15M 56.39M 45.16M 39.44M 22.62M
Interest Expense
3.42M 3.04M 2.7M 1.89M 1.4M 1.6M 1.7M 2.29M 2.58M 2.28M 2.02M 5.5M 6.31M 7.2M 7.03M 3.14M 1.96M 769K
Selling & Marketing Expenses
n/a n/a n/a -2.3M -2.3M -2.3M -2.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
45.37M 63.15M 69.81M 75.79M 75.56M 79.46M 78.11M 86.71M 95.03M 98.78M 101.19M 101.8M 98.91M 102.53M 88.47M 72M 58.49M 37.31M
Income Tax Expense
121K 61K 61K 126K 221K 221K 221K 108K 23K -41K 63K 8.38M 5M 1.64M 1.63M -5.78M -2.38M 1.97M
Shares Outstanding (Basic)
23.29M 22.61M 22.15M 20.54M 19.99M 19.76M 19.32M 18.42M 18.01M 17.81M 17.73M 17.62M 17.46M 17.32M 13.23M 9.16M 9.13M 9.16M
Shares Outstanding (Diluted)
23.29M 22.61M 22.15M 20.54M 19.99M 19.76M 19.32M 21.03M 18.01M 17.81M 17.73M 17.62M 17.46M 17.32M 13.24M 9.16M 9.16M 9.16M
EPS (Basic)
-0.39 -0.4 -0.75 -0.93 0.10 -0.19 -0.22 -0.71 -2.19 -2.16 -1.68 -2.72 -3.31 -4.18 -4.07 -2.28 -1.12 0.21
EPS (Diluted)
-0.39 -0.4 -0.75 -0.93 -0.01 -0.3 -0.33 -0.82 -2.19 -2.16 -1.68 -2.72 -3.31 -4.18 -4.07 -2.28 -1.12 0.21
EBITDA
-2.35M -1.43M -8.4M -12.97M 5.82M 1.26M 1.92M -5.69M -32.15M -31.73M -23.18M -23.25M -26.74M -33.64M -32.63M -19.82M -7.23M 7.31M
EBIT
-2.4M -5.2M -11.91M -16.32M 2.47M -2.34M -1.93M -9.95M -36.62M -36.15M -27.55M -26.85M -29.99M -36.8M -35.33M -22.38M -9.49M 5.99M
Depreciation & Amortization
2.93M 3.77M 3.52M 3.35M 3.35M 3.6M 3.85M 4.26M 4.47M 4.42M 4.37M 3.61M 3.25M 2.97M 2.54M 2.43M 2.13M 1.72M